HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

High Dimension

This article was originally published in The Rose Sheet

Executive Summary

Mascara and eye liner extensions will feature proprietary "light-interplay" technology based on colored, reflective crystals to create subtle, striking color, Revlon says. Products will debut in September in conjunction with High Dimension Hair Color (1"The Rose Sheet" May 7, p. 4). High Dimension mascara will be available in Black Flash, Black Sapphire, Black Garnet and Bronze Brown. Liner will debut in six shades - Black Flash, Steel Flash, Bronzed Flash, Sapphire Flash, Garnet Flash and Gold Flash. Products will retail for $7.50 each in mass outlets

You may also be interested in...



Revlon High Dimension Hair Color To Be Supported By TV, Print Ads

Revlon High Dimension hair color line, debuting in August, will be supported by a TV and print ad campaign developed by Kirshenbaum Bond & Partners (New York City), Revlon said. Ads will break in late summer.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009222

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel